{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT07707778","recordId":"NCT07707778","peptideSlug":"tirzepatide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07707778-tirzepatide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct07707778.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct07707778.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2026-07-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"tirzepatide","submittedDate":"2026-07-12","publishedAt":"2026-08-23","recordId":"NCT07707778","recordSha256":"0feafaddcd0320ba041d738b3dfd88c8c5b84db9183c5fc24211d1a3c79c0bca","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07707778?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2026-07-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"tirzepatide","submittedDate":"2026-07-16","publishedAt":"2026-08-23","recordId":"NCT07707778","recordSha256":"3a1ceba943082c061b8cdda1db40210f5291b4aa407fdbf2573d73a0d3fd4011","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07707778?a=2&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"15edbbaab9f0a186a18ebd494e044ebf8617c7b8f66e7401ab0c56769c2f3fc0"}}